Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
U.S. Food and Drug Administration (FDA)
Headquarters: Silver Spring, MD, United States of America
Website: http://www.fda.gov
Year Founded: 1906
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Mar 27, 2025
Regulation
FDA hit by massive cuts that could lead it to miss PDUFA goals
Cuts devised by acting commissioner with no input from center directors
BioCentury | Mar 27, 2025
Politics, Policy & Law
Makary, Bhattacharya confirmed, now the hard part starts
The FDA commissioner and NIH director are taking charge of agencies in crisis
BioCentury | Mar 26, 2025
Management Tracks
FDA names Barclay Butler COO
Plus: Scott Gottlieb named chair of Illumina, and updates from Syncromune and OSR
BioCentury | Mar 18, 2025
Politics, Policy & Law
Short window to halt FDA brain drain
Trump administration personnel policies are driving experienced staff to quit
BioCentury | Mar 18, 2025
Politics, Policy & Law
BIO’s Trump 2.0 plan. Plus: Autoimmune CAR Ts & Telix’s radiopharma play — a BioCentury podcast
Trade group CEO John Crowley hopes that by engaging with President Trump he can help protect and improve FDA
BioCentury | Mar 15, 2025
Politics, Policy & Law
It’s been a year: BIO CEO Crowley’s plans for Trump 2.0
BIO is engaging Trump to protect and improve FDA, hoping to dodge tariffs, looking for paths to modify IRA and reinstate PRVs
BioCentury | Mar 13, 2025
Politics, Policy & Law
Abortion, vaccine politics overshadow votes on heads of FDA, NIH
Senate committee endorsement of Makary at FDA and Bhattacharya at NIH came after resignation of FDA chief counsel, withdrawal of CDC director nominee
BioCentury | Mar 12, 2025
Politics, Policy & Law
House spending bill omits PRV reauthorization, slashes biomedical research program
Fate of continuing resolution in doubt as Senate Democrats balk ahead of Friday deadline to avert government shutdown
BioCentury | Mar 11, 2025
Politics, Policy & Law
Makary’s FDA agenda, amylin in obesity and life after DEI
Pending confirmation for new head of FDA will cap a tumultuous transition
BioCentury | Mar 10, 2025
Politics, Policy & Law
FDA reviewers, inspectors excluded from buyout offer
As HHS seeks to trim payroll, it is trying to prevent cuts from impacting medical product approvals
Items per page:
1 - 10 of 1762